EMNEastman Chemical Company
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for ~2% a year FCF growth. Little growth is priced in even as revenue fell 3% a year over three years, potential value, or a value trap.
Expensive vs its own history: P/E 16.3 vs a 10.8 median over 41 quarters (+51% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What EMN's price assumes
Eastman Chemical Company trades at 16.3× earnings against 29.4× for the median Specialty Chemicals name, cheaper than its own group.
Trailing P/E · Specialty Chemicals median 29.4 · cheaper than the typical name in its group
- Price / sales
- 0.91
Price / sales · today's price, trailing year to Jun 30, 2026
- Free cash flow yield
- 6.7%
Free cash flow yield · Specialty Chemicals median 4.7%
- Growth the price implies
- +1.8%
Growth the price implies · The price pays for +1.8% free cash flow growth a year for a decade; the business has delivered +16% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 1.32
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1.42
- Basic Materials median P/E203 names
- 20.7
- Specialty Chemicals median P/E43 names
- 29.4
- Free cash flow, trailing twelve months
- $539M
- Market capitalisation
- $8.07B
- 3-year revenue growth
- −3.4%
- 3-year free cash flow growth
- +16%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $32.35 |
| Its own P/E history, median | $41.65 |
| Its own P/E history, upper quartile | $53.36 |
| 52-week range | $54.37 – $79.49 |
| Today | $62.72 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.